Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Partners LP

51.11
-0.4300-0.83%
Post-market: 51.110.00000.00%16:04 EDT
Volume:22.04K
Turnover:1.13M
Market Cap:1.73B
PE:16.34
High:52.00
Open:52.00
Low:50.91
Close:51.54
Loading ...

Eli Lilly’s Strategic Advantage in GLP-1RAs and Alzheimer’s Markets Fuels Buy Rating

TIPRANKS
·
Yesterday

GLP J-REIT Secures Interest Rate Stability with Swap Agreement

TIPRANKS
·
18 Jul

Mark Romaine, Chief Operating Officer, Reports Disposal of Global Partners LP Common Shares

Reuters
·
17 Jul

19.2% Weight Reduction Achieved! Hengrui Pharma Reports Positive Phase III Topline Results for Dual GLP-1/GIP Agonist HRS9531 in Chinese Obesity Study

Market Watcher
·
16 Jul

19.2% Weight Reduction! HENGRUI PHARMA (01276) Reports Positive Topline Results from China Phase III Obesity Trial of GLP-1/GIP Dual Agonist HRS9531

Stock Track
·
15 Jul

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market

GlobeNewswire
·
15 Jul

FTC Release: FTC Takes Action Against Telemedicine Firm NextMed Over Charges It Used Misleading Prices, Fake Reviews, and Deceptive Weight Loss Claims to Sell GLP-1 Weight-Loss Programs

Dow Jones
·
14 Jul

Global Partners LP Announces Quarterly Cash Distribution of $0.59375 Per Unit on Series B Preferred Units

Reuters
·
14 Jul

Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery

GlobeNewswire
·
14 Jul

GLP J-REIT Announces Strategic Debt Refinancing Amid Rising Interest Rates

TIPRANKS
·
11 Jul

GMX Releases $40 Million Vulnerability Exploitation Event Recap: Further Discussion on Compensation Measures

Blockbeats
·
11 Jul

SlowMist: The core reason for the GMX attack is that the global short average price of GMX v1 can be manipulated, causing the GLP price to be maliciously inflated for arbitrage.

Blockbeats
·
10 Jul

GMX: GMX V1 trading on Arbitrum and Avalanche as well as GLP minting and redeeming have been temporarily paused, V2 and GMX token are unaffected

Blockbeats
·
09 Jul

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

GlobeNewswire
·
08 Jul

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks
·
04 Jul

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

Motley Fool
·
02 Jul

Mark Romaine, Chief Operating Officer, Reports Disposal of Common Shares in Global Partners LP

Reuters
·
26 Jun

Omada Health releases new data on its GLP-1 companion program

TIPRANKS
·
17 Jun

Global Partners Lp Announces Expiration and Results of Its Cash Tender Offer for Any and All of Its Outstanding 7.00% Senior Notes Due 2027

THOMSON REUTERS
·
17 Jun

BRIEF-Global Partners LP Announces Pricing Terms Of Cash Tender Offer

Reuters
·
17 Jun